Researchers have identified mutations in the carboxypeptidase D (CPD) gene as a significant cause of congenital hearing loss. This study revealed three missense variants of the CPD gene linked to deafness in five individuals from three families. Analyses confirmed a strong association between rare CPD mutations and hearing loss. The enzyme plays a critical role in nitric oxide production, with mutations reducing its activity and affecting cell health, leading to increased oxidative stress and cell death. The findings could expand diagnostic testing and treatment options for congenital hearing loss.
1. CPD mutations linked to congenital hearing loss. 2. Study revealed three missense variants. 3. Strong genetic association confirmed. 4. Involvement of nitric oxide in cell health. 5. Increased oxidative stress in affected fibroblasts. 6. Structural defects in auditory organs observed in fruit flies. 7. Potential for arginine supplementation as treatment. 8. Importance of molecular genetics in understanding hearing loss.
Listen Tab content
